Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials

被引:92
作者
Gould, Rebecca L. [1 ]
Coulson, Mark C. [2 ]
Patel, Natasha [1 ]
Highton-Williamson, Elizabeth [1 ]
Howard, Robert J. [1 ]
机构
[1] Kings Coll London, Inst Psychiat, Dept Old Age Psychiat, London WC2R 2LS, England
[2] Middlesex Univ, Sch Hlth & Educ, Dept Psychol, Hendon, England
关键词
PSYCHOTROPIC-DRUG USE; COGNITIVE-BEHAVIORAL THERAPY; INAPPROPRIATE MEDICATION USE; DOUBLE-BLIND; GENERAL-PRACTITIONERS; NURSING-HOMES; WITHDRAWAL; DISCONTINUATION; ADULTS; DEPENDENCE;
D O I
10.1192/bjp.bp.113.126003
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background The use Cif benzodiazepines has been advised against in older people, but prevalence rates remain high. Aims To review the evidence for interventions aimed at reducing benzodiazepine use in older people. Method We conducted a systematic review, assessment of risk of bias and meta-analyses of randomised controlled trials of benzodiazepine withdrawal and prescribing interventions. Results Ten withdrawal and eight prescribing studies met the inclusion criteria. At post-intervention, significantly higher odds of not using benzodiazepines were found with supervised withdrawal with psychotherapy (odds ratio (OR)=5.06, 95% Cl 2.68-9.57, P<0.00001) and withdrawal with prescribing interventions (OR=1.43; 95% Cl 1.02-2.02, P=0.04) in comparison with the control interventions treatment as usual (TAU), education placebo, withdrawal with or without drug placebo, or psychotherapy alone. Significantly higher odds of not using benzodiazepines were also found for multifaceted prescribing interventions (OR=1.37, 95% Cl 1.10-1.72, P=0.006) in comparison with control interventions (TAU and prescribing placebo). Conclusions Supervised benzodiazepine withdrawal augmented with psychotherapy should be considered in older people, although pragmatic reasons may necessitate consideration of other strategies such as medication review.
引用
收藏
页码:98 / 107
页数:10
相关论文
共 86 条
  • [1] [Anonymous], 2001, NAT SERV FRAM OLD PE
  • [2] [Anonymous], GUIDELINES PREVENTIO
  • [3] [Anonymous], INTERVENCION FARMACE
  • [4] [Anonymous], 2011, BR J GEN PRACT
  • [5] [Anonymous], 2012, STAT STAT SOFTW REL
  • [6] [Anonymous], CHIEF MED OFF UPD 37
  • [7] [Anonymous], 2009, INT STAT REV
  • [8] [Anonymous], REV MANAGER REVMAN C
  • [9] [Anonymous], WORLD EC SOC SURV
  • [10] [Anonymous], JPN J PHARMACOEPIDEM